CPT code 83014 designates a laboratory procedure in which drugs are administered to detect Helicobacter pylori infection in the stomach lining. This test is clinically relevant for diagnosing H. pylori–associated gastritis and peptic ulcer disease and informs antimicrobial treatment decisions. Nationally, accurate laboratory identification of H. pylori supports appropriate antibiotic selection and public health tracking of infection prevalence.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context, typical sites of service, and the kinds of benchmarks and policy considerations that commonly accompany laboratory procedure coding, such as coverage parameters, coding specificity, and billing practice guidance. Where available, the publication summarizes typical payment benchmarks, common modifiers used with lab procedures, and any recent payer policy updates affecting coverage and documentation requirements.

The report provides practical context for payers, coding professionals, and laboratory managers: clinical rationale for testing, expected laboratory workflows, and the national policy implications of coding consistency for surveillance and reimbursement. Data not available in the input will be noted as such in the detailed sections.